{"id":8460,"date":"2023-08-08T04:26:04","date_gmt":"2023-08-08T04:26:04","guid":{"rendered":"https:\/\/mysourcefunding.com\/leadership\/biotech-startup-10x-genomics-is-using-tech-to-transform-biology-and-advance-human-health-for-all-people-including-the-disabled\/"},"modified":"2023-08-08T04:26:05","modified_gmt":"2023-08-08T04:26:05","slug":"biotech-startup-10x-genomics-is-using-tech-to-transform-biology-and-advance-human-health-for-all-people-including-the-disabled","status":"publish","type":"post","link":"https:\/\/mysourcefunding.com\/?p=8460","title":{"rendered":"Biotech Startup 10X Genomics Is Using Tech To Transform Biology and \u2018Advance Human Health\u2019 For All People\u2014Including The Disabled"},"content":{"rendered":"
\n

Serge Saxonov, co-founder and chief executive officer of Bay Area-based 10X Genomics, started the biotech company in 2012. On its website, the company describes its mission as \u201c[delivering] powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health.\u201d Its work focuses on, it says, “innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.\u201d 1OX Genomics\u2019 work has been cited in more than 5,000 papers and has earned numerous innovation accolades from The Scientist<\/em>, most recently in 2021.<\/p>\n

Late last week, 10X Genomics issued a press release in which they announced their Q2 2023 financial results. The company reported revenue of $146.8 million, a 28% increase year-over-year in the corresponding quarter.<\/p>\n

\u201cThere\u2019s so much potential in the areas of life science and biology,\u201d Saxonov said to me in a recent interview by phone. \u201cI like to think of this [time period] as the \u2018century of biology.\u2019 Some of the biggest, most transformative things in the world are going to come from the life sciences in the coming decades.\u201d<\/p>\n

The reason for this bullishness, Saxonov told me, is the industry is on what he called an \u201cexponential trajectory of progress\u201d in which scientists can envision finding cures for various cancers and other diseases such as Alzheimer\u2019s. Looking at this bullishness from the intersection of disability and technology, it isn\u2019t hard to share Saxonov\u2019s optimism. As I wrote last year regarding Best Foot Forward<\/em> on Apple TV+, although it\u2019s obvious cancer is chiefly disabling and debilitating to the patient, its reverberating effects can have a profound impact on others in one\u2019s orbit, particularly when it comes to emotional wellbeing and mental health. Likewise, caregiving and disability intersect in myriad ways, and caring for a family member or friend with Alzheimer\u2019s is an arduous endeavor. There is a lot of biological and other scientific minutiae to the work Saxonov and team are doing; in a nutshell, however, the advances have the potential to immeasurably benefit humanity\u2014people with disabilities very much included.<\/p>\n

<\/fbs-ad><\/p>\n

Of course, technology has been the main driver of 10X Genomics\u2019 work, insofar as the rapidity with which technology progresses nowadays is a true boon for scientists who are navigating biology at the cellular level. Moreover, Saxonov called spatial biology, which involves the study of cells in context of its surroundings, the \u201chottest\u201d segment of molecular biology.<\/p>\n

10X Genomics\u2019 bread-and-butter product is its Xenium software, which launched last December, allows researchers to visualize and analyze cells.<\/p>\n

For people who aren\u2019t scientists and doctors, such as those who are disabled, for instance, Saxonov told me the overarching belief at his company is the work they do will \u201cadvance human health in profound ways.\u201d The so-called \u201cstrong conviction\u201d in the impact of their work has two elements, he added. One is the intellectual rigor, whereby scientists and doctors are fascinated by tools such as artificial intelligence in doing their jobs. The second is, again, the unwavering belief that the discoveries made by 10X Genomics will contribute to the greater good of humanity. Saxonov was forthright in telling me were someone in his family diagnosed with cancer, he\u2019d run the biopsy through his company\u2019s tools in order to determine how best to treat it.<\/p>\n

In terms of feedback, Saxonov said scientists generally are \u201cvery excited\u201d by the work 10X Genomics is doing, as well as by the technologies they\u2019re bringing to the field. Scientists, he added, are typically the company\u2019s first customers because they have insight into \u201cthe long-term vision of biology and where the science is going\u201d and can see \u201cwhat our technologies enable\u201d when it comes to actual work.<\/p>\n

As to the future, Saxonov told me the primary objective is on helping cure diseases and, in the process, help people. At a fundamental level, the team at 10X Genomics hopes its technologies will prove instrumental in curing diseases like cancer. Whereas in the company\u2019s early days, they were excited, Saxonov said, to get published in scientific papers, the main motivating factor nowadays is to build tools and technologies that enable breakthroughs in biology.<\/p>\n

\u201cWhat I find most rewarding, and I think it applies to everyone at the company, is being able to use our tools to point to a cancer and enable [scientists] to make it into a thing of the past,\u201d Saxonov said.<\/p>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Serge Saxonov, co-founder and chief executive officer of Bay Area-based 10X Genomics, started the biotech company in 2012. On its website, the company describes its mission as \u201c[delivering] powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health.\u201d Its work focuses on, it says, “innovative single cell, […]<\/p>\n","protected":false},"author":1,"featured_media":8461,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[76],"tags":[],"class_list":{"0":"post-8460","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-leadership"},"yoast_head":"\nBiotech Startup 10X Genomics Is Using Tech To Transform Biology and \u2018Advance Human Health\u2019 For All People\u2014Including The Disabled | Brandiary<\/title>\n<meta name=\"description\" content=\"Serge Saxonov, co-founder and chief executive officer of Bay Area-based 10X Genomics, started the biotech company in 2012. On its website, the company\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mysourcefunding.com\/?p=8460\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biotech Startup 10X Genomics Is Using Tech To Transform Biology and \u2018Advance Human Health\u2019 For All People\u2014Including The Disabled | Brandiary\" \/>\n<meta property=\"og:description\" content=\"Serge Saxonov, co-founder and chief executive officer of Bay Area-based 10X Genomics, started the biotech company in 2012. On its website, the company\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mysourcefunding.com\/?p=8460\" \/>\n<meta property=\"og:site_name\" content=\"Brandiary\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-08T04:26:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-08T04:26:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mysourcefunding.com\/wp-content\/uploads\/2023\/08\/1691468764_0x0.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"674\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mysourcefunding.com\/?p=8460#article\",\"isPartOf\":{\"@id\":\"https:\/\/mysourcefunding.com\/?p=8460\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/mysourcefunding.com\/#\/schema\/person\/5062dafb0f932b59aa228f1a047332f4\"},\"headline\":\"Biotech Startup 10X Genomics Is Using Tech To Transform Biology and \u2018Advance Human Health\u2019 For All People\u2014Including The Disabled\",\"datePublished\":\"2023-08-08T04:26:04+00:00\",\"dateModified\":\"2023-08-08T04:26:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mysourcefunding.com\/?p=8460\"},\"wordCount\":758,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/mysourcefunding.com\/#organization\"},\"articleSection\":[\"Leadership\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/mysourcefunding.com\/?p=8460#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mysourcefunding.com\/?p=8460\",\"url\":\"https:\/\/mysourcefunding.com\/?p=8460\",\"name\":\"Biotech Startup 10X Genomics Is Using Tech To Transform Biology and \u2018Advance Human Health\u2019 For All People\u2014Including The Disabled | Brandiary\",\"isPartOf\":{\"@id\":\"https:\/\/mysourcefunding.com\/#website\"},\"datePublished\":\"2023-08-08T04:26:04+00:00\",\"dateModified\":\"2023-08-08T04:26:05+00:00\",\"description\":\"Serge Saxonov, co-founder and chief executive officer of Bay Area-based 10X Genomics, started the biotech company in 2012. On its website, the company\",\"breadcrumb\":{\"@id\":\"https:\/\/mysourcefunding.com\/?p=8460#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mysourcefunding.com\/?p=8460\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mysourcefunding.com\/?p=8460#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/mysourcefunding.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biotech Startup 10X Genomics Is Using Tech To Transform Biology and \u2018Advance Human Health\u2019 For All People\u2014Including The Disabled\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mysourcefunding.com\/#website\",\"url\":\"https:\/\/mysourcefunding.com\/\",\"name\":\"Brandiary\",\"description\":\"Latest Business and Startup News and Updates\",\"publisher\":{\"@id\":\"https:\/\/mysourcefunding.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mysourcefunding.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mysourcefunding.com\/#organization\",\"name\":\"Brandiary\",\"url\":\"https:\/\/mysourcefunding.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mysourcefunding.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mysourcefunding.com\/wp-content\/uploads\/2023\/06\/b-logo-1.png\",\"contentUrl\":\"https:\/\/mysourcefunding.com\/wp-content\/uploads\/2023\/06\/b-logo-1.png\",\"width\":381,\"height\":100,\"caption\":\"Brandiary\"},\"image\":{\"@id\":\"https:\/\/mysourcefunding.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/mysourcefunding.com\/#\/schema\/person\/5062dafb0f932b59aa228f1a047332f4\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mysourcefunding.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/mysourcefunding.com\/wp-content\/uploads\/2023\/06\/avatar_user_1_1688031660-96x96.png\",\"contentUrl\":\"https:\/\/mysourcefunding.com\/wp-content\/uploads\/2023\/06\/avatar_user_1_1688031660-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/mysourcefunding.com\"],\"url\":\"https:\/\/mysourcefunding.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biotech Startup 10X Genomics Is Using Tech To Transform Biology and \u2018Advance Human Health\u2019 For All People\u2014Including The Disabled | Brandiary","description":"Serge Saxonov, co-founder and chief executive officer of Bay Area-based 10X Genomics, started the biotech company in 2012. On its website, the company","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mysourcefunding.com\/?p=8460","og_locale":"en_US","og_type":"article","og_title":"Biotech Startup 10X Genomics Is Using Tech To Transform Biology and \u2018Advance Human Health\u2019 For All People\u2014Including The Disabled | Brandiary","og_description":"Serge Saxonov, co-founder and chief executive officer of Bay Area-based 10X Genomics, started the biotech company in 2012. On its website, the company","og_url":"https:\/\/mysourcefunding.com\/?p=8460","og_site_name":"Brandiary","article_published_time":"2023-08-08T04:26:04+00:00","article_modified_time":"2023-08-08T04:26:05+00:00","og_image":[{"width":1200,"height":674,"url":"https:\/\/mysourcefunding.com\/wp-content\/uploads\/2023\/08\/1691468764_0x0.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mysourcefunding.com\/?p=8460#article","isPartOf":{"@id":"https:\/\/mysourcefunding.com\/?p=8460"},"author":{"name":"News Room","@id":"https:\/\/mysourcefunding.com\/#\/schema\/person\/5062dafb0f932b59aa228f1a047332f4"},"headline":"Biotech Startup 10X Genomics Is Using Tech To Transform Biology and \u2018Advance Human Health\u2019 For All People\u2014Including The Disabled","datePublished":"2023-08-08T04:26:04+00:00","dateModified":"2023-08-08T04:26:05+00:00","mainEntityOfPage":{"@id":"https:\/\/mysourcefunding.com\/?p=8460"},"wordCount":758,"commentCount":0,"publisher":{"@id":"https:\/\/mysourcefunding.com\/#organization"},"articleSection":["Leadership"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mysourcefunding.com\/?p=8460#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mysourcefunding.com\/?p=8460","url":"https:\/\/mysourcefunding.com\/?p=8460","name":"Biotech Startup 10X Genomics Is Using Tech To Transform Biology and \u2018Advance Human Health\u2019 For All People\u2014Including The Disabled | Brandiary","isPartOf":{"@id":"https:\/\/mysourcefunding.com\/#website"},"datePublished":"2023-08-08T04:26:04+00:00","dateModified":"2023-08-08T04:26:05+00:00","description":"Serge Saxonov, co-founder and chief executive officer of Bay Area-based 10X Genomics, started the biotech company in 2012. On its website, the company","breadcrumb":{"@id":"https:\/\/mysourcefunding.com\/?p=8460#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mysourcefunding.com\/?p=8460"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mysourcefunding.com\/?p=8460#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mysourcefunding.com\/"},{"@type":"ListItem","position":2,"name":"Biotech Startup 10X Genomics Is Using Tech To Transform Biology and \u2018Advance Human Health\u2019 For All People\u2014Including The Disabled"}]},{"@type":"WebSite","@id":"https:\/\/mysourcefunding.com\/#website","url":"https:\/\/mysourcefunding.com\/","name":"Brandiary","description":"Latest Business and Startup News and Updates","publisher":{"@id":"https:\/\/mysourcefunding.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mysourcefunding.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mysourcefunding.com\/#organization","name":"Brandiary","url":"https:\/\/mysourcefunding.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mysourcefunding.com\/#\/schema\/logo\/image\/","url":"https:\/\/mysourcefunding.com\/wp-content\/uploads\/2023\/06\/b-logo-1.png","contentUrl":"https:\/\/mysourcefunding.com\/wp-content\/uploads\/2023\/06\/b-logo-1.png","width":381,"height":100,"caption":"Brandiary"},"image":{"@id":"https:\/\/mysourcefunding.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/mysourcefunding.com\/#\/schema\/person\/5062dafb0f932b59aa228f1a047332f4","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mysourcefunding.com\/#\/schema\/person\/image\/","url":"https:\/\/mysourcefunding.com\/wp-content\/uploads\/2023\/06\/avatar_user_1_1688031660-96x96.png","contentUrl":"https:\/\/mysourcefunding.com\/wp-content\/uploads\/2023\/06\/avatar_user_1_1688031660-96x96.png","caption":"News Room"},"sameAs":["https:\/\/mysourcefunding.com"],"url":"https:\/\/mysourcefunding.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/mysourcefunding.com\/index.php?rest_route=\/wp\/v2\/posts\/8460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mysourcefunding.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mysourcefunding.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mysourcefunding.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mysourcefunding.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8460"}],"version-history":[{"count":1,"href":"https:\/\/mysourcefunding.com\/index.php?rest_route=\/wp\/v2\/posts\/8460\/revisions"}],"predecessor-version":[{"id":8462,"href":"https:\/\/mysourcefunding.com\/index.php?rest_route=\/wp\/v2\/posts\/8460\/revisions\/8462"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mysourcefunding.com\/index.php?rest_route=\/wp\/v2\/media\/8461"}],"wp:attachment":[{"href":"https:\/\/mysourcefunding.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mysourcefunding.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mysourcefunding.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}